American Capital Advisory’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
American Capital Advisory's IDXX Position: Q2 2026 in Review
American Capital Advisory reduced its Idexx Laboratories (IDXX) stake by 33% in Q2 2026, selling an estimated $561 and leaving 2 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #775.
American Capital Advisory first reported a position in IDXX in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.69K in Q1 2026. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- American Capital Advisory held 2 shares of Idexx Laboratories worth $1.05K as of Q2 2026.
- American Capital Advisory sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
- Idexx Laboratories made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #775 holding.
- American Capital Advisory first reported a position in Idexx Laboratories in Q1 2025 and has held it in 4 quarters since.
- American Capital Advisory's Idexx Laboratories position peaked at $1.69K in Q1 2026.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.